Click here to go to the previous page
Transfusion-Related Iron Overload/Iron Toxicity
Program Code:
9312-TC
Date:
Monday, October 24, 2011
Time:
10:30 AM to 12:00 PM
EST
SPEAKER
(S):
Jeffrey Wagner, BSN, RN, Chief Transfusion Safety Officer, Puget Sound Blood Center
Susan Carson, MSN, CPNP, Nurse Practitioner, Hematology, Children's Hospital of Los Angeles
Aryeh Shander, MD, FCCM, FCCP, Chief, Dept of Anesthesiology, Critical Care & Hyperbaric Medicine Englewood Hospital and Medical Center, Clinical Prof of Anes, Medicine & Surgery Mount Sinai School of Medicine, Mount Sinai Hospital, New York, Englewood Hospital & Medical Center
Description
Transfusion-related iron overload (TRIO)/iron toxicity is a serious adverse outcome of red blood cell transfusions for those patients receiving approximately 20 units of RBCs or more over their lifetime for non-bleeding diagnoses. Patients transfused with 20 or more RBCs for treatment of myelodysplastic syndrome (MDS), sickle cell disease (SCD), Diamond-Blackfan anemia (DBA), ∝-thalassemia, or bone marrow transplant (BMT) should be monitored for TRIO and for when chelation treatment may be indicated. This presentation will discuss monitoring, diagnosis, and treatment of transfusion-related iron overload/iron toxicity.
CE Category | CE Value |
---|
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.